See allMeet us September 08, 2020 Aktiedagen, Aktiespararna September 14-15, 2020 New York - 22nd Annual Global Investment Conference, H.C. Wainwright October 07, 2020 CNS seminar, Redeye
Proprietary Pipeline Read more about our Proprietary Pipeline We have a broad portfolio of potential drug candidates in preclinical or clinical stages. Tesomet for treatment of Prader-Willi Syndrome and Hypothalamic Obesity See more SAN711 for the treatment of rare neuropathic pain and itching disorders See more SAN903 for the treatment of rare inflammatory disorders and certain hereditary hematological diseases See more Next